Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Dec-23 6:00 PM View:  | Ipi Legacy Liquidation Co (IMPLQ) | 19-Dec-23 | Sale | 237,289 | $0.08 | $18,983.10 | (9%) 2.55M to 2.31M | |
| 19-Dec-23 6:00 PM View: | Ipi Legacy Liquidation Co (IMPLQ) | 18-Dec-23 | Sale | 237,711 | $0.11 | $26,148.20 | (9%) 2.78M to 2.55M | |
| 19-Dec-23 6:00 PM View: | Ipi Legacy Liquidation Co (IMPLQ) | 15-Dec-23 | Sale | 100,000 | $0.29 | $29,000.00 | (3%) 2.88M to 2.78M | |
| 22-Nov-23 6:51 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 21-Nov-23 | Sale | 3,400 | $0.90 | $3,060.00 | (< 1%) 3.79M to 3.78M | |
| 20-Nov-23 10:00 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 20-Nov-23 | Sale | 54,700 | $0.92 | $50,324.00 | (< 1%) 7.81M to 7.76M | |
| 20-Nov-23 10:00 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 17-Nov-23 | Sale | 16,354 | $0.93 | $15,209.20 | (< 1%) 7.83M to 7.81M | |
| 20-Nov-23 10:00 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 16-Nov-23 | Sale | 15,000 | $0.96 | $14,400.00 | (< 1%) 7.84M to 7.83M | |
| 29-Apr-21 9:10 PM View: | Ipi Legacy Liquidation Co (IMPLQ) | 27-Apr-21 | Conversion | 2,309,790 | $0.59 | $1,369,660.00 | 100% 0 to 2.31M | |
| 29-Apr-21 9:10 PM View: | Ipi Legacy Liquidation Co (IMPLQ) | 27-Apr-21 | Market Purchase | 575,000 | $15.00 | $8,625,000.00 | 25% 2.31M to 2.88M | |
| 09-Feb-21 3:37 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Conversion | 3,414,340 | -- | -- | 7967% 42.86K to 3.46M | |
| 09-Feb-21 3:37 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Purchase | 350,000 | $20.00 | $7,000,000.00 | 10% 3.46M to 3.81M | |
| 09-Feb-21 3:37 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Sale | 226 | $20.00 | $4,520.00 | (< 1%) 3.87M to 3.87M | |
| 09-Feb-21 3:37 PM View: | Bolt Biotherapeutics, Inc. (BOLT) | 09-Feb-21 | Exercise (in-the money or at-the-money) | 64,319 | $0.07 | $4,502.33 | 2% 3.81M to 3.87M | |
| 09-Feb-21 3:08 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 09-Feb-21 | Conversion | 2,200,130 | -- | -- | 100% 0 to 2.2M | |
| 09-Feb-21 3:08 PM View: | Terns Pharmaceuticals, Inc. (TERN) | 09-Feb-21 | Purchase | 475,000 | $17.00 | $8,075,000.00 | 22% 2.2M to 2.68M | |
| 20-Oct-20 4:59 PM View: | Aligos Therapeutics, Inc. (ALGS) | 20-Oct-20 | Conversion | 2,997,030 | -- | -- | 100% 0 to 3.0M | |
| 20-Oct-20 4:59 PM View: | Aligos Therapeutics, Inc. (ALGS) | 20-Oct-20 | Purchase | 550,000 | $15.00 | $8,250,000.00 | 18% 3.0M to 3.55M | |
| 17-Apr-20 6:38 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 17-Apr-20 | Market Sale | 84,598 | $15.40 | $1,302,810.00 | (3%) 2.55M to 2.46M | |
| 17-Apr-20 6:38 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 16-Apr-20 | Market Sale | 30,190 | $15.20 | $458,888.00 | (1%) 2.58M to 2.55M | |
| 17-Apr-20 6:38 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-20 | Market Sale | 215,810 | $15.50 | $3,345,060.00 | (8%) 2.79M to 2.58M | |
| 07-Apr-20 7:27 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 07-Apr-20 | Market Sale | 6,115 | $14.20 | $86,833.00 | (< 1%) 2.8M to 2.79M | |
| 07-Apr-20 7:27 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 03-Apr-20 | Market Sale | 300,000 | $13.80 | $4,140,000.00 | (10%) 3.1M to 2.8M | |
| 11-Mar-20 5:12 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 09-Mar-20 | Market Sale | 528 | $19.50 | $10,296.00 | (< 1%) 3.27M to 3.27M | (10%) |
| 11-Feb-20 8:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 10-Feb-20 | Market Sale | 7,555 | $21.40 | $161,677.00 | (< 1%) 3.27M to 3.27M | (< 1%) |
| 11-Feb-20 8:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 07-Feb-20 | Market Sale | 5,905 | $22.00 | $129,910.00 | (< 1%) 3.28M to 3.27M | 2% |
| 06-Feb-20 7:22 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 04-Feb-20 | Market Sale | 13,460 | $22.80 | $306,888.00 | (< 1%) 3.29M to 3.28M | 6% |
| 31-Jan-20 8:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 31-Jan-20 | Market Sale | 5,400 | $21.70 | $117,180.00 | (< 1%) 3.3M to 3.29M | 1% |
| 31-Jan-20 8:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 30-Jan-20 | Market Sale | 7,600 | $22.10 | $167,960.00 | (< 1%) 3.31M to 3.3M | 3% |
| 31-Jan-20 8:00 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 29-Jan-20 | Market Sale | 13,920 | $22.20 | $309,024.00 | (< 1%) 3.32M to 3.31M | 3% |
| 27-Jun-19 5:00 PM View: | BioPharmX Corporation (TMBR) | 25-Jun-19 | Market Sale | 327,870 | $1.02 | $334,427.00 | (51%) 645.14K to 317.27K | 90% |
| 25-Mar-19 6:04 AM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-19 | Market Sale | 417,000 | $22.25 | $9,278,250.00 | (11%) 3.74M to 3.32M | (6%) |
| 20-Jul-18 4:50 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Jul-18 | Conversion | 3,384,280 | -- | -- | 100% 0 to 3.38M | |
| 20-Jul-18 4:50 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 20-Jul-18 | Purchase | 353,180 | $18.62 | $6,575,420.00 | 10% 3.38M to 3.74M | |
| 09-Mar-18 4:01 PM View: | BioPharmX Corporation (TMBR) | 07-Mar-18 | Market Sale | 2,000,000 | $0.36 | $720,000.00 | (11%) 18.13M to 16.13M | 98% |
| 31-Jan-18 4:30 PM View: | BioPharmX Corporation (TMBR) | 30-Jan-18 | Conversion | 4,328,570 | -- | -- | 31% 13.8M to 18.13M | |
| 29-Jan-18 4:17 PM View: | Vyne Therapeutics Inc. (VYNE) | 29-Jan-18 | Conversion Duplicate | 3,717,120 | -- | -- | 1264% 294.12K to 4.01M | |
| 29-Jan-18 4:17 PM View: | Vyne Therapeutics Inc. (VYNE) | 25-Jan-18 | Purchase Duplicate | 294,118 | $17.00 | $5,000,010.00 | 100% 0 to 294.12K | |
| 13-Nov-17 6:50 PM View: | BioPharmX Corporation (TMBR) | 09-Nov-17 | Market Sale | 296,394 | $0.20 | $59,278.80 | (2%) 14.1M to 13.8M | 97% |
| 18-Sep-17 9:13 PM View: | Nabriva Therapeutics Plc (NBRV) | 18-Sep-17 | Market Purchase | 52,631 | $9.46 | $497,889.00 | 1% 4.02M to 4.07M | (97%) |